AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 152 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $980,000 | +92.5% | 28,450 | -6.6% | 0.00% | – |
| Q2 2020 | $509,000 | +17.3% | 30,467 | +1.3% | 0.00% | – |
| Q1 2020 | $434,000 | -59.7% | 30,066 | -6.6% | 0.00% | -100.0% |
| Q4 2019 | $1,077,000 | +163.3% | 32,180 | +64.6% | 0.00% | – |
| Q3 2019 | $409,000 | +0.5% | 19,550 | 0.0% | 0.00% | – |
| Q2 2019 | $407,000 | -1.5% | 19,550 | +5.8% | 0.00% | – |
| Q1 2019 | $413,000 | -5.5% | 18,481 | +1.1% | 0.00% | – |
| Q4 2018 | $437,000 | +13.2% | 18,273 | +29.1% | 0.00% | – |
| Q3 2018 | $386,000 | +1.3% | 14,150 | 0.0% | 0.00% | – |
| Q2 2018 | $381,000 | -15.1% | 14,150 | +0.3% | 0.00% | – |
| Q1 2018 | $449,000 | +29.8% | 14,102 | +55.2% | 0.00% | – |
| Q4 2017 | $346,000 | +56.6% | 9,087 | +1.5% | 0.00% | – |
| Q3 2017 | $221,000 | +38.1% | 8,955 | +15.2% | 0.00% | – |
| Q2 2017 | $160,000 | +19.4% | 7,776 | +26.6% | 0.00% | – |
| Q1 2017 | $134,000 | +4.7% | 6,142 | -1.5% | 0.00% | – |
| Q4 2016 | $128,000 | +137.0% | 6,238 | +66.4% | 0.00% | – |
| Q3 2016 | $54,000 | -41.3% | 3,749 | -54.7% | 0.00% | – |
| Q2 2016 | $92,000 | – | 8,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|